ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658257 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658257; 2) Community: the network communities that were significantly associated with the response to NSC 658257; 3) Molecule: the relationships between components within communities and NSC 658257; 4) MDR: the compounds that were significantly associated with the NSC 658257.

NSC Compound Enrichment Correlation
NSC 731356 2 -Amino-6-(ethylthio)-4-(furan-2-yl)pyridine-3,5-dicarbonitri le 0.0285477013888565 -0.11556887
NSC 287459 Cytarabine AY 0.0285477013888568 0.061503463
NSC 135880 Null 0.0297837393005855 -0.14560973
NSC 244404 Null 0.0297837393005855 0.038578237
NSC 300289 Pinafide 0.0297837393005855 -0.019082629
NSC 303812 Aphidicoline glycinate 0.0297837393005855 -0.057784136
NSC 303861 L-Cysteine analog 0.0297837393005855 -0.18292167
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0297837393005855 0.059338047
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0297837393005855 -0.20947379
NSC 629229 Null 0.0297837393005855 -0.20413817
Total:35  Current:19    [First] [Prev] [Next] [Last]